Alvogen Issues Voluntary Nationwide Recall for One Lot of Fentanyl Transdermal System 25 mcg/h Due to a Defective Delivery System

Posted on by

Company Contact Information Consumers: 866-770-3024 alvogensmb@continuumindia.com Press: Alvogenpress@mercuryllc.com MORRISTOWN, N.J., Jan. 31, 2025 /PRNewswire/ — Alvogen, Inc. is voluntarily recalling one lot of Fentanyl Transdermal System 25 mcg/h transdermal patches to the consumer…